0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Stage
Employees
Links
Hugh Y. Rienhoff, Jr.
5 members
Bio-Rad Laboratories
11 followers
Adaptive Biotechnologies
Agilent Technologies
60 followers
Regeneron
77 followers
Biogen
93 followers
Discover companies